Carrick launches to conquer cancer | Chemical & Engineering News
Volume 94 Issue 40 | p. 15 | Concentrates
Issue Date: October 10, 2016

Carrick launches to conquer cancer

Department: Business
Keywords: start-ups, biotech, oncology

Backed by $95 million in funding, Carrick Therapeutics has launched with the lofty goal of becoming the leading oncology company in Europe. The biotech start-up has yet to provide substantive details on its scientific strategy but says it will build a portfolio of first-in-class treatments that target the most aggressive and resistant forms of cancer. Carrick has R&D teams in Oxford, Eng­land, and Dublin that are working on three therapeutic programs. It intends to expand its pipeline through academic and pharma ­partnerships.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment